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Abstract
Background: The burden of malnutrition among HIV-infected children is not well described in sub-Saharan Africa,
even though it is an important problem to take into account to guarantee appropriate healthcare for these children.
We assessed the prevalence of malnutrition and its associated factors among HIV-infected children in HIV care
programmes in Central and West-Africa.
Methods: A cross-sectional study was conducted from September to December 2011 among the active files of
HIV-infected children aged 2–19 years old, enrolled in HIV-care programmes supported by the Sidaction Growing Up
Programme in Benin, Burundi, Cameroon, Côte d’Ivoire, Mali, Chad and Togo. Socio-demographics characteristics,
anthropometric, clinical data, and nutritional support were collected. Anthropometric indicators, expressed in Z-scores,
were used to define malnutrition: Height-for-age (HAZ), Weight-for-Height (WHZ) for children < 5 years and BMI-for-age
(BAZ) for children ≥5 years. Three types of malnutrition were defined: acute malnutrition (WHZ/BAZ < -2 SD and HAZ≥ -2
SD), chronic malnutrition (HAZ < -2 SD and WHZ/BAZ≥ -2 SD) and mixed malnutrition (WHZ/BAZ < -2 SD and HAZ < -2
SD). A multinomial logistic regression model explored associated factors with each type of malnutrition.
Results: Overall, 1350 HIV-infected children were included; their median age was 10 years (interquartile range [IQR]: 7–13
years), 49 % were girls. 80 % were on antiretroviral treatment (ART), for a median time of 36 months. The prevalence of
malnutrition was 42 % (95 % confidence interval [95% CI]: 40-44 %) with acute, chronic and mixed malnutrition at 9 %
(95% CI: 6–12 %), 26 % (95% CI: 23–28 %), and 7 % (95% CI: 5–10 %), respectively. Among those malnourished, more than
half of children didn’t receive any nutritional support at the time of the survey. Acute malnutrition was associated with
male gender, severe immunodeficiency, and the absence of ART; chronic malnutrition with male gender and age
(<5 years); and mixed malnutrition with male gender, age (<5 years), severe immunodeficiency and recent ART initiation
(<6 months). Orphanhood and Cotrimoxazole prophylaxis were not associated with any type of malnutrition.
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Conclusions: The prevalence of malnutrition in HIV-infected children even on ART remains high in HIV care programmes.
Anthropometric measurements and appropriate nutritional care of malnourished HIV-infected children remain insufficient
and a priority to improve health care of HIV-infected children in Africa.
Keywords: HIV, Children, Malnutrition, Nutritional support, Africa
Background
In 2012, 3.3 million children were living with Human
Immunodeficiency Virus (HIV) worldwide, with more
than 90 % in sub-Saharan Africa [1]. Regardless of HIV,
sub-Saharan Africa is also the region of the world the
most seriously affected by malnutrition, 21 % of children
under 5 years are underweight, 39 % are stunted, and
9 % are wasted [2]. Malnutrition is the underlying cause
of death among 35 % of children aged <5 years [3], and
could lead to irreversible damages such as cognitive im-
pairment, chronic diseases and growth failure [4].
Therefore, malnutrition is a major problem for chil-
dren and especially for HIV-infected children since it
creates a vicious circle with HIV infection. Indeed, on
the one hand, malnutrition worsens HIV disease as it
has similar effects on the immune system as HIV infec-
tion. For example, among malnourished people, lymph-
oid tissues are damaged, and CD4 T-cell concentration
is decreased [5]. Deficiencies in vitamins and minerals
contribute to oxidative stress, which can accelerate im-
mune cell death [6] and increase HIV replication [7]. On
the other hand, HIV infection increases the risk of mal-
nutrition, because of a high pro-inflammatory cytokine
activity which can cause growth impairment among chil-
dren [8]. HIV-related opportunistic infections such as
persistent diarrhoea or oral and oesophageal candidiasis
have a negative impact on nutritional status among
children [9]. HIV infection can also indirectly affect the
child’s nutritional status, when it has an impact on the
child’s social environment. In some contexts, when HIV
concerns the most productive members of the family,
the household economic capacities and the agricultural
production are reduced, leading to a situation of food
insecurity [10]. Furthermore, poor weaning practices
among HIV-infected mothers can also have an impact
on the child’s nutritional status [11].
Thus, malnutrition is a common complication among
HIV-infected children. Low weight-for-age has been re-
ported in up to 50 % of untreated HIV-infected children
in resource-limited settings [12]. Among children with
severe malnutrition, mortality risk is three times higher
in HIV-infected children than in non-HIV-infected
children [13]. Thus, nutritional care is fully part of the
paediatric HIV healthcare package. The World Health
Organisation recommends that an asymptomatic HIV-
infected child should increase his energy requirements
by 10 %, compared to a non-infected child; this is ex-
tended to 20 to 30 % during symptomatic HIV infection
or episodes of opportunistic infections, and up to 50 to
100 % when a severe malnutrition episode occurs [14].
However, the burden of malnutrition remains difficult to
quantify in HIV-infected people, most of all in children.
A better understanding of this problem and its associ-
ated factors is necessary to improve HIV paediatric
healthcare, especially in sub-Saharan Africa. Thus, we
conducted a cross-sectional study, to assess the preva-
lence and associated factors of acute and chronic malnu-
trition among HIV-infected children followed up in the
HIV-care programmes in Central and West Africa
funded by the Growing Up programme.
Methods
Study population
The Growing Up programme is supported by two
French NGOs: Sidaction and Initiative Développement,
and supports 17 associations in 10 Central and West-
African countries, taking care of HIV-infected children
and their families through a comprehensive approach.
Twelve of the associations participated in the study, in
seven African countries: Benin, Burundi, Cameroon,
Côte d’Ivoire, Mali, Chad and Togo. Nine of these asso-
ciations are located in capital cities and three in other
major cities, mainly in urban or peri-urban areas. After
HIV diagnosis, children received medical treatment
(Cotrimoxazole prophylaxis, treatment of acute oppor-
tunistic infections, antiretroviral therapy [ART] if eligible
according to the 2010 WHO guidelines [15], and nutri-
tional support). Children were followed-up at least every
2 months.
Nutritional support was usually provided to severely
malnourished children identified according to the sites
modalities, usually composed of, either an enriched flour
or flour-sugar-oil mixture, or ready-to-use therapeutic
foods such as Plumpy nut. For every centre, nutritional
support was mainly used for children under two years of
age to assist the weaning period. No specific nutritional
protocol was defined for older children. The nutritional
assessment was not yet routinely implemented at the
time of the survey.
Data from each centre were collected and entered into
a database with the formal approval of each participating
clinical site. There were neither extra exams nor blood
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draws, nor extra data collection compared to the standard
of care offered in each site. This study has been conducted
in accordance with the principles of the Declaration of
Helsinki of the World Medical Association. Parent’s verbal
consent was collected during the conduct of the study,
and all data records analysed in the database were
anonymized.
Study design
A cross-sectional study was conducted between Septem-
ber and December 2011 among all HIV-infected children
enrolled in 12 of the Growing Up Programme partnering
associations. Children included in the study were those
with a confirmed HIV-infection (a positive serology for
children older than 18 months, or a positive polymerase
chain reaction [PCR] whatever the age), aged between 2
and 19 years old, ART-treated or not, with available data
for gender, age, weight and height and HIV care at the
time of the survey, and who had been seen at least once
in the programme during the study period.
Data management and variables
Data collection was standardised for each participating
site, with a fact sheet. Data were collected during the
follow-up routine visits and extracted from the medical
records to be further centralised in a global database.
Several types of data were collected: weight and height,
measured during the survey visit according to the WHO
recommendations [14], age during the survey expressed
in categorical form ([2–5[, [5–10[, and [10–19[ years),
the last CD4 count in cells/μL or in % less than 6 months
before the study, clinical stage defined by the 2006
WHO guidelines [16], orphan status, information on
HIV treatment, type of ART regimen and its duration
(more or less than 6 months) and cotrimoxazole prophy-
laxis, and the type of the nutritional support (flour, pow-
dered milk, solid or semi-solid foods, or Ready-to-Use
Therapeutic Food [RUTF]) received during the study
period and during the last six months prior to the study
period. If a child had received at least one nutritional
support before the study, we hypothesised that he had
suffered from malnutrition and created a variable “mal-
nutrition history”. CD4 was used in percentage for chil-
dren < 5 years and in cells/μL for children ≥ 5 years and
we defined immunodeficiency for age according to the
2006 WHO definitions [16]. Severe immunodeficiency
was defined by CD4% < 15 or CD4/μL < 350, and mod-
erate immunodeficiency by CD4% = [15–25[, or CD4/
μL = [350–499[.
To define malnutrition, several anthropometric indica-
tors are used according to WHO definitions: Height-for-
Age, for children up to 19 years, Weight-for-Height for
children < 5 years and BMI-for-Age for children ≥ 5 years,
and Weight-for-age, for children < 10 years. These
indicators are standardised using Z-scores, which quan-
tify how many Standard Deviations (SDs) child’s weight
and height is from the median value of a child of the
same age and sex, in a reference population. For this
analysis, we used the 2006 WHO growth charts for chil-
dren <5 [17], and the 2007 WHO growth charts for chil-
dren ≥ 5 [18]. Each indicator allows to define three types
of malnutrition: wasting when Weight-for-Height Z-
score (WHZ) or BMI-for-Age Z-score (BAZ) < -2 SD,
stunting when Height-for-Age Z-score (HAZ) < -2 SD, and
underweight when Weight-for-Age Z-score (WAZ) < -2
SD. A child is defined as moderately malnourished if the Z-
score is between -3 and -2 SD, and severely malnourished if
the Z-score < -3 SD. Z-scores were calculated using WHO
Anthro Software (version 3.2.2, January 2011) and WHO
AnthroPlus.
In this study, we combined these indicators to define
three categories of malnutrition: (1) acute malnutrition
defined by WHZ or BAZ < -2 SD and HAZ ≥ -2 SD; (2)
chronic malnutrition defined by WHZ/BAZ ≥ -2 SD
and HAZ < -2 SD, and (3) mixed malnutrition as WHZ/
BAZ < -2 SD and HAZ < -2 SD. WAZ was not used here.
Statistical analysis
Characteristics of the HIV-infected children included
were first described by age group, then by the type of
malnutrition (acute, chronic, and mixed malnutrition).
Comparisons were made using the Pearson χ2 test for
qualitative variables and the Kruskal-Wallis test for quan-
titative variables. Prevalences of malnutrition according to
the three anthropometric indicators were calculated with
their 95 % confidence interval. A multinomial regression
model was fitted to study the associated factors to the
three types of malnutrition. All explanatory variables with
P < 0.25 in bivariate analyses were selected for multivariate
analyses. Potential explanatory variables included age
group, gender, immunodeficiency for age, history and dur-
ation on ART, malnutrition history, orphan status, cotri-
moxazole prophylaxis and country. Missing data were
conserved in the analysis, creating a separate modality. Be-
cause WHO clinical stage is determined by severe clinical
manifestations including malnutrition status [16], we
chose to exclude this variable from multivariate analyses.
Results
Characteristics of the population
Between September and December 2011, 2027 children
were seen in the 12 participating centres of the Growing
up Programme, representing more than 90 % of the ac-
tive files. Among them, 1407 (69 %) had a confirmed
diagnosis of HIV-infection. Of these children, 22 % were
excluded for age criteria and 35 % for missing data.
Finally, 1350 HIV-infected children were included in
our study (Fig. 1). Their median age was 10 years
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(interquartile range [IQR] = [7–13]), 49 % were girls,
60 % were orphans for one or both parents, 77 % were
on cotrimoxazole prophylaxis and 80 % were on ART for
a median duration of 36 months (IQR = [18–61]). Of
these children, 22 % had reached WHO clinical stage III
or IV of HIV disease and 17 % were severely immunode-
ficient. Among the 237 children not on ART at the time
of the study, 13 % were eligible (stage 3 or 4, or severely
immunodeficient). More than 55 % of the included chil-
dren did not receive any nutritional support at the time
of the study or in the past 6 months (Table 1). Among
the 45 % of children receiving nutritional support at in-
clusion, less than 2 % had received RUTF; and solid or
semi-solid foods were the most frequently used (>80 %).
Except for gender, all children characteristics differed
significantly according to age groups (Table 1). More
than half of the children between 2 and 5 years had
missing CD4 data. The 2–5 and 5–10 years groups were
at a more advanced clinical stage of HIV disease than
the 10–19 years group (25 % vs 19 % at clinical stage III
or IV, p = 0.002). Compared with the 5–10 and 10–19
years groups, the 2–5 years group had received more
important nutritional support prior to the study (19 % vs
12–13 % with at least 3 supports, p < 0.001) and also
during the study (11 % vs 5 % with 3 supports, p <
0.001). The youngest children were also less often or-
phans compared with older children (71 % of 2–5 years
no orphans vs 51 % of 5–10 years vs 23 % of 10–19
years, p < 0.001) (Table 1).
Prevalence of malnutrition
In the overall study population, 42 % of children were mal-
nourished with 123 children (9 %, 95% CI = [6–12]) suffer-
ing from acute malnutrition, 344 (26 %, 95% CI = [23–28])
from chronic malnutrition, and 100 (7 %, 95% CI = [5–10])
from mixed malnutrition (Fig. 1). In other words, 16 % of
children were wasted and 33 % were stunted with, in both
cases, 36 % of them severely malnourished.
The prevalence of malnutrition differed significantly
by age. Among children aged 2–5 years, half were mal-
nourished, and we observed the highest rate of chronic
malnutrition among this age group reaching 37 %
(compared to 24 % in both 5–10 and 10–19 year old
groups). Children aged 5–10 years were malnourished
in 36 % of cases, and children aged 10 to 19 years in
44 % (Table 2).
Among the non-malnourished children, 45 % re-
ceived at least one nutritional support before or during
the study. Among the malnourished children at the
time of the survey, whatever the type of malnutrition,
53 % received at least one nutritional support before or
during the study. This nutritional support was more
frequent for children between 2 and 5 years of age with
no malnutrition, acute or chronic malnutrition, com-
pared with older children (p < 0.001, p = 0.001 and p =
0.005 respectively). Children with mixed malnutrition
and aged between 5 and 10 had more frequently a nu-
tritional support compared with the other age groups
(p = 0.025). Also, among children who had a nutritional
Fig. 1 Selection of the population and prevalence of acute, chronic and mixed malnutrition (95 % Confidence Interval [CI])
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Table 1 Characteristics of the 1350 HIV-infected children of the study population according to age groups
Variables Age group in years P-value* Total (n = 1350)
[2–5] [5–10] [10–19]
(n = 161) (n = 505) (n = 684)
Gender, n, % 0.839
Female 78 48 254 50 333 49 665 49
Male 83 52 251 50 351 51 685 51
CD4%, median, IQR† 31 24–37 - - - - - 31 24–37
CD4/mm3, median, IQR‡ - - 788 505–1162 556 362–797 <0.001 642 412–952
Immunodeficiency by age§ , n, % <0.001
No immunodeficient 57 35 363 72 382 56 802 59
Moderate 15 9 52 10 129 19 196 15
Severe 6 4 65 13 152 22 223 17
Missing 83 52 25 5 21 3 129 10
WHO Clinical stage§, n, % 0.002
I 70 44 223 44 380 56 673 50
II 48 30 137 27 157 23 342 25
III 25 16 89 18 98 14 212 16
IV 16 10 40 8 34 5 90 7
Missing 2 1 16 3 15 2 33 2
Nutritional support within 6 months prior to the study||, n, % <0.001
None 59 37 246 49 399 58 704 52
1 support 54 34 152 30 144 21 350 26
2 supports 15 9 34 7 51 8 100 7
3–4 supports 31 19 65 13 82 12 178 13
Missing 2 1 8 2 8 1 18 1
Nutritional support during the study||, n, % <0.001
None 68 42 261 52 418 61 747 55
1 support 55 34 161 32 157 23 373 28
2 supports 18 11 53 11 72 11 143 11
3 supports 17 11 25 5 31 5 73 5
Missing 3 2 5 1 6 1 14 1
Treatment, n, % <0.001
No treatment 4 3 13 3 14 2 31 2
Cotrimoxazole only 40 25 107 21 73 11 220 16
ART only 25 16 107 21 131 19 263 20
Cotrimoxazole + ART 90 56 271 54 459 67 820 61
Missing 2 1 7 1 7 1 16 1
Orphans status, n, % <0.001
Single (father deceased) 32 20 110 22 136 20 278 21
Single (mother deceased) 12 8 71 14 130 19 213 16
Double 2 1 62 12 248 36 312 23
No orphan 115 71 255 51 158 23 528 39
Missing 0 0 7 1 12 2 19 1
Country, n, % <0.001
Benin 5 3 25 5 18 3 48 4
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support, most of them were supported both before and
during the study, whatever the malnutrition degree
(Table 3).
Factors associated with acute malnutrition
More than half of children suffering from acute malnu-
trition were aged > 10 years; 63 % were boys, 37 % were
known to be either moderately or severely immunodefi-
cient and 27 % were reported to be at a WHO clinical
stage III or IV, although unexplained moderate or severe
malnutrition are criteria for classifying an HIV-infected
child at these stages. Furthermore, 63 % of children pre-
senting acute malnutrition didn’t receive any nutritional
support during the study. Moreover, 66 % were initiated
on ART for more than 6 months and 20 % were not yet
receiving ART (Table 4).
In univariate analysis, acute malnutrition was significantly
twice as high in boys as in girls, and in children with severe
immunodeficiency compared to those not (OR = 2.13, 95%
CI = [1.44–3.16] and OR= 2.27, 95% CI = [1.43–3.62] re-
spectively) (Table 5).
In the adjusted analysis for age group, sex, country,
immunodeficiency, malnutrition history, duration on
ART and orphan status, boys were twice more likely
malnourished than girls (aOR = 2.27, 95% CI = [1.52–
3.41]), as well severely immunodeficient children com-
pared to non-immunodeficient children (aOR = 2.07,
95% CI = [1.25–3.42]), and non-ART-treated children
compared with those on ART for more than 6 months
(aOR = 1.70, 95% CI = [1.01–2.84]) (Table 5).
Factors associated with chronic malnutrition
Among children suffering from chronic malnutrition,
47 % were aged >10 years, 55 % were boys, 30 % were
moderately or severely immunodeficient and 28 % were
reported to be at and advanced clinical stage (III or IV).
Among these children, 43 % hadn’t received any nutri-
tional support during the 6 months prior to the study,
9 % were recently initiated on ART and 18 % were not
receiving ART (Table 4).
In univariate analysis, chronic malnutrition was sig-
nificantly twice as low in children older than 5 years of
age as in younger children ([5–10[ vs. [2–5[ : OR = 0.51,
95% CI = [0.34–0.75], [10–19[ vs. [2–5[: OR = 0.57,
95% CI = [0.39–0.84]), higher in boys compared to girls
(OR = 1.50, 95% CI = [1.16–1.94]), in children with missing
immunological data (OR = 1.76, 95% CI = [1.17–2.65]), in
children ART-initiated for less than 6 months com-
pared to children on ART since more than 6 months
(OR = 1.74, 95% CI = [1.06–2.85]), and in those who had
an history of malnutrition (OR = 1.73, 95% CI = [1.34–
2.23]) (Table 5).
In the adjusted analysis for age group, sex, country,
immunodeficiency, malnutrition history, duration on
ART and orphan status, the risk of chronic malnutrition
was reduced in children aged 5–10 years compared to
those aged 2–5 years (aOR = 0.61, 95% CI = [0.38–0.99]).
On the other hand, chronic malnutrition was more
likely among boys compared to girls (aOR = 1.56, 95%
CI = [1.20–2.03]). Children who had received nutritional
support within the 6 months prior to the study were
Table 1 Characteristics of the 1350 HIV-infected children of the study population according to age groups (Continued)
Burundi 15 9 108 21 333 49 456 34
Cameroun 7 4 24 5 25 4 56 4
Côte d’Ivoire 43 27 100 20 104 15 247 18
Mali 40 25 79 16 54 8 173 13
Tchad 27 17 50 10 43 6 120 9
Togo 24 15 119 24 107 16 250 19
*Chi-square test for qualitative variables, Kruskal-Wallis test for quantitative variables
†children < 5 years, n’ = 78, ‡children ≥5 years, n’ = 480 for 5–10 years, n’ = 663 for 10–19 years, §WHO 2006 guidelines, ||Number of different nutritional support
given (flour, powdered milk, solid or semi-solid foods, RUTF)




Age group in years (p-value <0.001*)
[2–5] [5–10] [10–19] Total
(n = 161) (n = 505) (n = 684) (n = 1350)
Acute malnutrition 10 6 (0;14) 44 9 (4;13) 69 10 (6;14) 123 9 (6;12)
Chronic malnutrition 59 37 (30;43) 122 24 (20;28) 163 24 (20;27) 344 26 (23;28)
Mixed malnutrition 13 8 (0;13) 17 3 (0;8) 70 10 (7;14) 100 7 (5;10)
*Chi-square test for the comparison of malnutrition prevalence according to age groups
†acute malnutrition : Weight-for-Age Z-score (WHZ)/BMI-for-age Z-score (BAZ) < -2 SD and Height-for-Age Z-score (HAZ) ≥ -2 SD, chronic malnutrition: WHZ/BAZ≥ -2 SD
and HAZ < -2 SD, mixed malnutrition: WHZ/BAZ and HAZ < -2 SD
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more likely malnourished compared to those not receiv-
ing any support (aOR = 1.99, 95% CI = [1.43–2.77])
(Table 5).
Factors associated with mixed malnutrition
Among children suffering from mixed malnutrition,
87 % were aged more than 10 years. There were 67 % of
boys, 45 % were moderately or severely immunodeficient
and 32 % were at an advanced clinical stage. Further-
more, 54 % hadn’t received any nutritional support dur-
ing the study and 51 % hadn’t received any during the
6 months prior to the study. Moreover, 12 % were re-
cently initiated on ART and 12 % were not receiving
ART (Table 4).
In univariate analysis, mixed malnutrition was signifi-
cantly twice as low in children aged 5 to 10 years of age
as in younger children (OR = 0.32, 95% CI = [0.15–
0.69]), higher in boys compared to girls (OR = 2.50, 95%
CI = [1.61–3.88]), as well as in children with severe im-
munodeficiency (OR = 3.22, 95% CI = [2.01–5.51]), and
in children ART-initiated for less than 6 months
compared to children on ART for more than 6 months
(OR = 2.40, 95% CI = [1.21–4.78]) (Table 5).
In the adjusted analysis for age group, sex, country,
immunodeficiency, malnutrition history, duration on
ART and orphan status, we observed lower risks of
mixed malnutrition in children aged 5–10 years com-
pared to 2–5 years (aOR = 0.34, 95% CI = [0.14–0.84]).
Risks of mixed malnutrition were higher among boys
compared to girls (aOR = 2.60, 95% CI = [1.64–4.10])
and among severely immunodeficient children com-
pared to non immunodeficient children (aOR = 2.43,
95% CI = [1.40–4.23]) and in those on ART for less than
6 months compared to children on ART for more than
6 months (aOR = 2.54, 95% CI = [1.17–5.55]) (Table 5).
Discussion
In this cross-sectional study conducted in 2011 among
1350 HIV-infected children receiving paediatric care in
12 associations of the Growing up Programme in sub-
Saharan Africa, we documented a high prevalence of
42 % of malnutrition, with acute, chronic and mixed
Table 3 Nutritional supplementation practices according to the type of malnutrition and age groups. N = 1350
Children on nutritional support according
to malnutrition degree*, n, %,
Age group in years Total P-
value†[2–5] [5–10] [10–19]
(n = 161) (n = 505) (n = 684) (n = 1350)
No malnutrition N = 79 N = 322 N = 382 N = 783
Nutritional support before the study only‡ 9 11 14 4 10 3 33 4 <0.001
Nutritional support during the study only 2 3 10 3 6 2 18 2
Nutritional support before and during the study 42 53 137 43 123 32 302 39
Total nutritional support 53 67 161 50 139 36 353 45 <0.001
Acute malnutrition N = 10 N = 44 N = 69 N = 123
Nutritional support before the study only 2 20 3 7 4 6 9 7 0,123
Nutritional support during the study only 0 0 1 2 1 1 2 2
Nutritional support before and during the study 6 60 16 36 20 29 42 34
Total nutritional support 8 80 20 45 25 36 53 43 0.001
Chronic malnutrition N = 59 N = 122 N = 163 N = 344
Nutritional support before the study only 3 5 6 5 7 4 16 5 0.667
Nutritional support during the study only 1 2 1 1 0 0 2 1
Nutritional support before and during the study 33 56 64 52 81 50 178 52
Total nutritional support 37 63 71 58 88 54 196 57 0.005
Mixed malnutrition N = 13 N = 17 N = 70 N = 100
Nutritional support before the study only 1 8 1 6 5 7 7 7 0.310
Nutritional support during the study only 2 15 0 0 2 3 4 4
Nutritional support before and during the study 4 31 10 59 27 39 41 41
Total nutritional support 7 54 11 65 34 49 52 52 0.025
*acute malnutrition : Weight-for-Age Z-score (WHZ)/BMI-for-age Z-score (BAZ) < -2 SD and Height-for-Age Z-score (HAZ) ≥ -2 SD, chronic malnutrition: WHZ/BAZ≥ -2 SD
and HAZ < -2 SD, mixed malnutrition: WHZ/BAZ and HAZ < -2 SD
†Comparison of the nutritional support according to age groups and for each type of malnutrition, distinguishing time to support or not, Chi-square tests and
Fisher tests if conditions of application not respected
‡In the last 6 months before the study
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Table 4 Baseline characteristics of the study population according to the type of malnutrition. N = 1350
Variables Acute malnutrition* Chronic malnutrition Mixed malnutrition Study population
(N = 123) (N = 344) (N = 100) (N = 1350)
N % N % N % N %
Age group in years
[2–5] 10 8 59 17 13 13 161 12
[5–10] 44 36 122 35 17 17 505 37
[10–19] 69 56 163 47 70 70 684 51
Gender
Female 45 37 155 45 33 33 665 49
Male 78 63 189 55 67 67 685 51
Immunodeficiency for age‡
No immunodeficient 70 57 195 57 45 45 802 59
Moderate 13 11 46 13 14 14 196 15
Severe 33 27 57 17 31 31 223 17
Missing 7 6 46 13 10 10 129 10
WHO clinical stage‡
I 50 41 139 40 43 43 673 50
II 34 28 101 29 23 23 342 25
III 16 13 73 21 24 24 212 16
IV 17 14 24 7 8 8 90 7
Missing 6 5 7 2 2 2 33 2
Nutritional support within 6 months
prior to the study||
None 69 56 148 43 51 51 704 52
1 support 21 17 100 29 19 19 350 26
2 supports 12 10 29 8 9 9 100 7
3–4 supports 18 15 65 19 20 20 178 13
Missing 3 2 2 1 1 1 18 1
Nutritional support during the study||
None 77 63 161 47 54 54 747 55
1 support 21 17 114 33 22 22 373 28
2 supports 17 14 36 11 12 12 143 11
3 supports 6 5 30 9 11 11 73 5
Missing 2 2 3 1 1 1 14 1
Duration of ART
<6 Months 11 9 30 9 12 12 94 7
≥6 Months 81 66 245 71 71 71 979 73
No yet started 25 20 63 18 12 12 237 18
Unknown 6 5 6 2 5 5 40 3
Cotrimoxazole prophylaxis
Yes 101 82 271 79 74 74 1040 77
No 21 17 69 20 26 26 294 22
Unknown 1 1 4 1 0 0 16 1
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malnutrition which were 9 %, 26 % and 7 % respectively.
This study provides also a snapshot of the nutritional
practices in field conditions. Among the malnourished
children in this study, more than half of the children
didn’t receive any nutritional support during the study
or within the 6 months prior to the study. Regarding as-
sociated factors, we report higher prevalence of malnu-
trition, whatever the type, among boys compared to
girls. Children between 2 and 5 years had more often
chronic or mixed malnutrition compared to children
between 5 and 10 years. Furthermore, as a marker of
HIV-disease progression, children with severe immuno-
deficiency or recently initiated on ART were more at
risk for acute or mixed malnutrition.
Our findings show overall, a high rate of malnutrition in
such a healthcare programme. Comparisons with others
studies are difficult because of the differences between
study population and definitions of malnutrition. Among
children aged 2–5 years in our study, 45 % were stunted
(chronic +mixed malnutrition) and 14 % were wasted
(acute +mixed malnutrition). Compared to a cross-
sectional survey conducted in Tanzania among ART-
treated HIV-infected children, we observe similar results
for wasting but report higher proportions of stunting [19].
The prevalence of malnutrition, whatever the type, was
higher than in our study for children initiating ART in
Malawi, with more than half of children malnourished
[20]. Among children between 2 and 5 years of age, we
also report similar rates of malnutrition than those in the
general population of children under five years in West
and Central Africa (39 % and 12 % for stunting and wast-
ing respectively) [2]. We observed that among HIV-
infected children, chronic malnutrition was more frequent
than other types. Indeed, because of HIV disease, these
children could have underlying problems of nutrition and
repeated opportunistic infections.
In our study, children aged 5–10 years suffered less
from chronic or mixed malnutrition than children aged
2–5 years. We can hypothesise that the younger children
were more advanced in the HIV-disease progression,
and were enrolled in the programme precisely because
they were more ill, causing malnutrition.
Boys were more likely to be malnourished than girls in
our study. A meta-analysis of 10 countries in Sub-
Saharan Africa has reported the same result among the
general population of children less than five years [21].
In a study conducted in Tanzania among children born
to HIV-infected mothers, boys were 28 %, 40 %, and
28 % more likely to be stunted, wasted, and underweight,
respectively, compared to girls [22]. The reasons of this
association between gender and malnutrition remain un-
clear and need further investigation [23].
We also noticed that children severely immunodeficient
were more likely to be malnourished than non-
immunodeficient children, supporting the fact that malnu-
trition and HIV infection are linked in a vicious circle.
Despite this association, we saw that overall half of the
malnourished children presented no signs of immunodefi-
ciency. For these children, malnutrition could not be ex-
plained by HIV-infection, but rather by an insufficient
nutritional support. Moreover, only 30 % of malnour-
ished children were classified at WHO clinical stage III
or IV, whereas malnutrition is one of the definitions for
stage III and IV for the WHO classification of HIV-
related diseases [16], suggesting that malnutrition is not
well detected in routine.
Table 4 Baseline characteristics of the study population according to the type of malnutrition. N = 1350 (Continued)
Orphan status
Single (father deceased) 17 14 67 20 23 23 278 21
Single (mother deceased) 21 17 62 18 19 19 213 16
Double orphan 33 27 70 20 26 26 312 23
No orphan 51 42 141 41 29 29 528 39
Missing 1 1 4 1 3 3 19 1
Country
Benin 5 4 17 5 3 3 48 4
Burundi 34 28 104 30 30 30 456 34
Cameroun 0 0 16 5 0 0 56 4
Côte d’Ivoire 26 21 60 17 29 29 247 18
Mali 24 20 47 14 19 19 173 13
Chad 7 6 41 12 4 4 120 9
Togo 27 22 59 17 15 15 250 19
*acute malnutrition : Weight-for-Age Z-score (WHZ)/BMI-for-age Z-score (BAZ) < -2 SD and Height-for-Age Z-score (HAZ) ≥ -2 SD, chronic malnutrition: WHZ/BAZ ≥ -2 SD
and HAZ < -2 SD, mixed malnutrition: WHZ/BAZ and HAZ < -2 SD
†Chi-square test, ‡WHO 2006 guidelines, ||Number of different nutritional supports given (flour, powdered milk, solid or semi-solid foods, RUTF)
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We found also an association between recent ART ini-
tiation, marker of the HIV-disease progression and
mixed malnutrition. We advise caution in interpreting
this result since we are unable to access which came
first, malnutrition or ART initiation. However, consider-
ing previous studies describing the benefits of ART on
weight and height gain [24–27]), we hypothesise that
these children were probably initiated on ART based on
clinical criteria such as malnutrition. Furthermore, we
found that non-ART-treated children were more likely
to present acute malnutrition compared to ART-treated
children.
Similarly, as a marker of malnutrition, children who
received a nutritional support six months prior the sur-
vey suffered more from chronic malnutrition than those
who didn’t received any nutritional support. These chil-
dren have probably been experiencing malnutrition
problems for several months, perhaps several years, lead-
ing to chronic malnutrition, which is difficult to reverse.
In our study, orphan status was not associated with
malnutrition, which is concordant with other results
among HIV-infected children in sub-Saharan Africa
[28–30], although other results have reported otherwise
[31]. In our context, we can explain our observation by
the specific healthcare received by orphaned children in
participating associations, reducing differences between
orphans and non orphans.
We didn’t find any association between cotrimoxazole
prophylaxis and growth in our study, whereas other
studies have reported positive effects of such prophylaxis
on growth. A study conducted with the Zambian CHAP
trial in HIV-infected children, who had not yet received
ART, reported that cotrimoxazole prophylaxis slowed
decrease in weight and height [32].
This study presents several limitations. First, children
included in this study had access to paediatric HIV
healthcare, mostly in urban areas where the standard of
care may be higher than that offered in rural areas,
Table 5 Factors associated with malnutrition (acute, chronic and mixed), univariate and multivariate multinomial logistic regressions.
N = 1350
Variable Acute malnutrition* Chronic malnutrition Mixed malnutrition
(N = 123) (N = 344) (N = 100)
OR† 95% CI aOR† 95% CI OR† 95% CI aOR 95% CI OR† 95% CI aOR 95% CI
Age group in years
[2–5] 1 - 1 - 1 - 1 - 1 - 1 -
[5–10] 1.08 (0.52–2.24) 0.91 (0.39–2.15) 0.51 (0.34–0.75) 0.61 (0.38–0.99) 0.32 (0.15–0.69) 0.34 (0.14–0.84)
[10–19] 1.43 (0.70–2.89) 1.57 (0.66–3.78) 0.57 (0.39–0.84) 0.78 (0.47–1.29) 1.11 (0.59–2.11) 1.32 (0.56–3.09)
Gender (Male/Female) 2.13 (1.44–3.16) 2.27 (1.52–3.41) 1.50 (1.16–1.94) 1.56 (1.20–2.03) 2.50 (1.61–3.88) 2.60 (1.64–4.10)
Immunodeficiency by age‡
No immunodeficient 1 - 1 - 1 - 1 - 1 - 1 -
Moderate 0.75 (0.40–1.39) 1.19 (0.47–3.02) 0.94 (0.65–1.38) 0.89 (0.60–1.31) 1.24 (0.66–2.34) 0.99 (0.51–1.91)
Severe 227 (1.43–3.62) 2.07 (1.25–3.42) 1.41 (0.98–2.03) 1.40 (0.96–2.06) 3.32 (2.01–5.51) 2.43 (1.40–4.23)
Missing 0.75 (0.33–1.69) 0.61 (0.23–1.63) 1.76 (1.17–2.65) 1.32 (0.78–2.23) 1.66 (0.80–3.44) 1.19 (0.47–3.02)
Duration of ART
≥6 months 1 - 1 - 1 - 1 - 1 - 1 -
6 months 1.93 (0.95–3.90) 1.80 (0.84–3.89) 1.74 (1.06–2.85) 1.58 (0.93–2.67) 2.40 (1.21–4.78) 2.54 (1.17–5.55)
No yet started 1.31 (0.81–2.13) 1.70 (1.01–2.84) 1.09 (0.78–1.53) 1.11 (0.78–1.58) 0.72 (0.38–1.36) 1.11 (0.56–2.18)
Missing 1.87 (0.74–4.74) 2.48 (0.92–6.63) 0.62 (0.25–1.54) 0.69 (0.27–1.77) 1.78 (0.66–4.83) 2.34 (0.79–6.91)
Malnutrition history (Yes/No)§ 0.95 (0.64–1.39) 1.23 (0.75–2.04) 1.73 (1.34–2.23) 1.99 (1.43–2.77) 1.23 (0.81–1.87) 1.67 (0.96–2.89)
Orphan status (Yes/No) || 0.91 (0.62–1.34) 0.84 (0.55–1.29) 0.93 (0.72–1.20) 1.03 (0.77–1.37) 1.58 (1.00–2.49) 1.39 (0.83–2.32)
Treatment Cotrimoxazole (/No)
Yes 1.44 (0.88–2.37) - - 1.18 (0.86–1.61) - - 0.85 (0.53–1.37) - -
Missing 0.77 (0.10–6.27) - - 0.94 (0.29–3.05) - - <0.001 - - -
*acute malnutrition : Weight-for-Age Z-score (WHZ)/BMI-for-age Z-score (BAZ) < -2 SD and Height-for-Age Z-score (HAZ) ≥ -2 SD, chronic malnutrition: WHZ/BAZ ≥ -2 SD
and HAZ < -2 SD, mixed malnutrition: WHZ/BAZ and HAZ < -2 SD
†OR = Odds Ratio, aOR = adjusted Odds Ratio, analyses adjusted on clinical centres
‡WHO 2006 guidelines
§Nutritional support 6 months prior the study
||Orphan status including both double and single orphans
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making results difficult to extrapolate to rural areas.
Second, we excluded the children < 2 years, because
too few respected the inclusion criteria. However, this
population is precisely known to be more vulnerable
and having more malnutrition problems [33, 34]. Fur-
thermore, since 50 % of HIV-infected children not ini-
tiated on ART die before their second birthday [34],
the sickest children could not have survived until the
survey period, leading to a survivor bias. So, the selec-
tion of the study population is not representative of a
birth cohort of HIV-infected children in sub-Saharan
Africa, leading to an underestimation of the prevalence
of malnutrition. Third, there are possible measurement
errors in weight and height; we limited this by using a
standard measurement protocol for all centres, follow-
ing the WHO recommendations [14]. However, per-
ipheral oedema, sign of severe malnutrition, was not
collected, despite their effect on increasing artificially
weight. Furthermore, because of our definition of mal-
nutrition (acute, chronic and mixed), 20 children with
a low weight-for-age were not defined as malnourished
and were misclassified in the analyses. Finally, the
cross-sectional study design didn’t allow to establish a
causal relationship between malnutrition and explana-
tory variables.
Nevertheless, the study included nearly all children en-
rolled in the 12 participating associations of the Growing
up Programme representing as best as possible HIV-
infected children enrolled in HIV care programmes in
West and Central Africa. Data collection was of high
quality in this study context, with more than 97 % of an-
thropometric data available. Most of all, very few studies
have reported the nutritional practices in HIV-infected
malnourished children, and although practices are not
detailed in our study, it highlights this gap and the need
to focus on these interventions in such children. Finally,
despite the possible biases that could have all underesti-
mated the prevalence, we hypothesize that we provided
a conservative estimate of the prevalence of malnutrition
in a large sample size of Central and West African chil-
dren, which can give us an idea of the picture of the
burden of malnutrition among HIV-infected children in
this region.
As a result, we report that anthropometric measure-
ments are not enough routinely performed in the field
conditions, and nutritional supplementation is not opti-
mally used and monitored in this context. Indeed, we
have seen that close to half of malnourished children
didn’t receive any nutritional support, before as well as
during the survey, whereas a substantial part of non-
malnourished children still had a nutritional support at
the moment of the survey. However, taking better into
account data on growth in HIV-care programmes could
be major to improve long-term paediatric HIV-care.
Conclusion
In conclusion, the prevalence of malnutrition remains
high for HIV-infected children in sub-Saharan Africa,
even in an HIV care programme supposed to have a high
standard of care. A better acknowledgement of this
problem is needed, that should lead to a better health-
care management of HIV-infected children, with active
routine anthropometric measurements easy to perform to
allow an earlier detection of malnutrition leading to an ap-
propriate nutritional package. Our study strengthens the
World Health Organization recommendation on the need
for a nutritional assessment and support that should be an
integral part of the care plan of HIV-infected children
[35]. Indeed, an early detection of growth impairment
could detect, for example, poor treatment response, poor
adherence to treatment, and could prevent morbidity and
mortality risks. Further studies about associated factors
with malnutrition, such as differences in sex need to be
examined more closely in prospective designs [23]. More-
over, food supplementation and multivitamin use may im-
prove the nutritional status of the children. Finally,
nutritional interventions should be tailored and assessed
to improve growth, especially at time of ART initiation
that could lead to an optimisation of their clinical re-
sponse and survival of ART-treated children.
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